Showing 1 to 2 of 2 clinical trials
|
CLINICAL TRIALS Trial No ClinicalTrials.gov ID |
Phase | Coordinator | |
|---|---|---|---|
|
Personalized Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: A Phase 2 Study
A14-11-2181 NCT02754297  Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL L'HOTEL-DIEU DE QUEBEC ET CRCEO |
Phase II |
Guillaume Bouvet 418-525-4444 |
|
A Randomized, Multi-center, Open-label, Active-controlled Phase 3 Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) Versus Octreotide LAR or Lanreotide ATG in Patients With GEP-NET
SORENTO NCT05050942 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Aline Mamo 514-340-8222 poste 5525 |
Groupe d'étude en oncologie du Québec